1887

Abstract

Cutibacterium acnes (C. acnes) can become an exacerbating factor in acne vulgaris. Clindamycin has been most frequently used for the treatment of inflammatory acne vulgaris. We studied clindamycin susceptibility and resistance determinants of C. acnes isolated from acne patients in Japan. The isolation rate of clindamycin-resistant C. acnes had significantly increased from 20.3 % in 2009–2010 to 44.1 % in 2016–2017. Strains carrying erm(X), which confers high-level resistance to clindamycin, had significantly increased from 1.4 to 11.8 %. Sequence analysis of the resistance determinant showed that erm(X) was coded on transposon Tn5432. A transconjugation experiment showed that erm(X) can be transferred between C. acnes strains with high frequency and the transconjugants harboured transposon Tn5432 encoding erm(X). Our data show the transconjugation of erm(X) in C. acnes and strongly suggest that the transmission of erm(X) between C. acnes contributes to the increase and spread of clindamycin-resistant C. acnes strains in acne patients.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000875
2018-11-15
2019-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jmm/68/1/26.html?itemId=/content/journal/jmm/10.1099/jmm.0.000875&mimeType=html&fmt=ahah

References

  1. McDowell A. Over a decade of recA and tly gene sequence typing of the skin bacterium Propionibacterium acnes: what have we learnt?. Microorganisms 2017;6:1 [CrossRef][PubMed]
    [Google Scholar]
  2. Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016;74:945.e33–973.e33 [CrossRef][PubMed]
    [Google Scholar]
  3. Nast A, Dréno B, Bettoli V, Degitz K, Erdmann R et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012;26:1–29 [CrossRef][PubMed]
    [Google Scholar]
  4. Hayashi N, Akamatsu H, Iwatsuki K, Shimada-Omori R, Kaminaka C et al. Japanese dermatological association guidelines: guidelines for the treatment of acne vulgaris 2017. J Dermatol 2018;45:898–935 [CrossRef][PubMed]
    [Google Scholar]
  5. Sardana K, Gupta T, Garg VK, Ghunawat S. Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management. Expert Rev Anti Infect Ther 2015;13:883–896 [CrossRef][PubMed]
    [Google Scholar]
  6. Ross JI, Eady EA, Carnegie E, Cove JH. Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities. J Antimicrob Chemother 2002;49:165–168 [CrossRef][PubMed]
    [Google Scholar]
  7. El-Mahdy TS, Abdalla S, El-Domany R, Mohamed MS, Ross JI et al. Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria. Anaerobe 2010;16:376–379 [CrossRef][PubMed]
    [Google Scholar]
  8. Ross JI, Eady EA, Cove JH, Jones CE, Ratyal AH et al. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother 1997;41:1162–1165 [CrossRef][PubMed]
    [Google Scholar]
  9. Nakase K, Nakaminami H, Takenaka Y, Hayashi N, Kawashima M et al. A novel 23S rRNA mutation in Propionibacterium acnes confers resistance to 14-membered macrolides. J Glob Antimicrob Resist 2016;6:160–161 [CrossRef][PubMed]
    [Google Scholar]
  10. Schwendener S, Perreten V. New MLSB resistance gene erm(43) in Staphylococcus lentus. Antimicrob Agents Chemother 2012;56:4746–4752 [CrossRef][PubMed]
    [Google Scholar]
  11. Nakase K, Nakaminami H, Takenaka Y, Hayashi N, Kawashima M et al. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan. J Med Microbiol 2014;63:721–728 [CrossRef][PubMed]
    [Google Scholar]
  12. He HJ, Sun FJ, Wang Q, Liu Y, Xiong LR et al. Erythromycin resistance features and biofilm formation affected by subinhibitory erythromycin in clinical isolates of Staphylococcus epidermidis. J Microbiol Immunol Infect 2016;49:33–40 [CrossRef][PubMed]
    [Google Scholar]
  13. Nakase K, Nakaminami H, Noguchi N, Nishijima S, Sasatsu M. First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris. J Dermatol 2012;39:794–796 [CrossRef][PubMed]
    [Google Scholar]
  14. Wang N, Hang X, Zhang M, Peng X, Yang H. New genetic environments of the macrolide-lincosamide-streptogramin resistance determinant erm(X) and their influence on potential horizontal transferability in bifidobacteria. Int J Antimicrob Agents 2017;50:572–580 [CrossRef][PubMed]
    [Google Scholar]
  15. Hays C, Lienhard R, Auzou M, Barraud O, Guérin F et al. Erm(X)-mediated resistance to macrolides, lincosamides and streptogramins in Actinobaculum schaalii. J Antimicrob Chemother 2014;69:2056–2060 [CrossRef][PubMed]
    [Google Scholar]
  16. Tauch A, Kassing F, Kalinowski J, Pühler A. The Corynebacterium xerosis composite transposon Tn5432 consists of two identical insertion sequences, designated IS1249, flanking the erythromycin resistance gene ermCX. Plasmid 1995;34:119–131 [CrossRef][PubMed]
    [Google Scholar]
  17. Nakase K, Hayashi N, Akiyama Y, Aoki S, Noguchi N. Antimicrobial susceptibility and phylogenetic analysis of Propionibacterium acnes isolated from acne patients in Japan between 2013 and 2015. J Dermatol 2017;44:1248–1254 [CrossRef][PubMed]
    [Google Scholar]
  18. CLSI National Committee for Clinical Laboratory Standards. Methods of Methods ofAntimicrobial Susceptibility Testing of Anaerobic Bacteria-Eighth Edition, Approved Standard M11-A8. 2012
    [Google Scholar]
  19. CLSI Perfomance Standard for Antimicrobial Susceptibility Testing; Twentieth informational supplement, Approved standard M100-S20. 2009
    [Google Scholar]
  20. CLSI Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically, Approved standard M07-A8. 2009
    [Google Scholar]
  21. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003;148:467–478 [CrossRef][PubMed]
    [Google Scholar]
  22. Gao Z, Perez-Perez GI, Chen Y, Blaser MJ. Quantitation of major human cutaneous bacterial and fungal populations. J Clin Microbiol 2010;48:3575–3581 [CrossRef][PubMed]
    [Google Scholar]
  23. Brüggemann H, Lomholt HB, Tettelin H, Kilian M. CRISPR/cas loci of type II Propionibacterium acnes confer immunity against acquisition of mobile elements present in type I P. acnes. PLoS One 2012;7:e34171 [CrossRef][PubMed]
    [Google Scholar]
  24. Guin JD, Lummis WL. Comedonal levels of free clindamycin following topical treatment with a 1% solution of clindamycin phosphate. J Am Acad Dermatol 1982;7:265–268 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000875
Loading
/content/journal/jmm/10.1099/jmm.0.000875
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error